0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Navigating recent studies: A Nordic perspective

Session 2: Migraine management in the Nordics

Ville Artto

MD, PhD, Senior Neurologist, Department of Neurology, Helsinki University Hospital, Finland

Download presentation

Previous

Migraine preventative treatment recommendations/reimbursement conditions in the Nordics – What has changed in the last 5-6 years?

Next

Children and adolescent as migraine patients - Diagnosis and management

You Might Also Like

Related Embedded Video Item Thumbnail Burden of disease in children and adolescent
Related Embedded Video Item Thumbnail Should we use combination therapy in migraine treatment? Con
Related Embedded Video Item Thumbnail Should we use combination therapy in migraine treatment? Pro
Related Embedded Video Item Thumbnail Switching between anti-CGRP monoclonal antibodies and gepants
Related Embedded Video Item Thumbnail Migraine preventative treatment recommendations/reimbursement conditions in the Nordics – What has changed in the last 5-6 years?

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct


Norway, Finland, Denmark: AJO-DK-NP-00128